Morgan Stanley Immucell Corp Transaction History

Morgan Stanley

$1.27 Trillion
Q2 2024

A detailed history of Morgan Stanley transactions in Immucell Corp stock. As of the latest transaction made, Morgan Stanley holds 66,816 shares of ICCC stock, worth $238,533. This represents 0.0% of its overall portfolio holdings.

Number of Shares

66,816

Previous 64,716 3.24%

Holding current value

$238,533

Previous $342,000 5.26%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Oct 17, 2024	BUY	$4.18 - $5.48 $8,778 - $11,508	2,100 Added 3.24%	66,816 $324,000
Q2 2024 Aug 14, 2024	BUY	$4.18 - $5.48 $8,778 - $11,508	2,100 Added 3.24%	66,816 $324,000
Q1 2024 Oct 17, 2024	SELL	$4.73 - $5.47 $9,933 - $11,487	-2,100 Reduced 3.14%	64,716 $342,000
Q1 2024 Aug 16, 2024	SELL	$4.73 - $5.47 $93,928 - $108,623	-19,858 Reduced 23.48%	64,716 $342,000
Q1 2024 May 15, 2024	SELL	$4.73 - $5.47 $93,928 - $108,623	-19,858 Reduced 23.48%	64,716 $342,000
Q4 2023 Aug 16, 2024	BUY	$4.45 - $5.47 $79,023 - $97,136	17,758 Added 26.58%	84,574 $430,000
Q4 2023 Feb 13, 2024	SELL	$4.45 - $5.47 $14,685 - $18,051	-3,300 Reduced 3.76%	84,574 $430,000
Q3 2023 Nov 15, 2023	BUY	$4.53 - $5.61 $58,437 - $72,369	12,900 Added 17.21%	87,874 $469,000
Q2 2023 Aug 14, 2023	BUY	$4.64 - $5.98 $16,704 - $21,528	3,600 Added 5.04%	74,974 $374,000
Q1 2023 May 15, 2023	SELL	$4.85 - $7.84 $26,674 - $43,120	-5,500 Reduced 7.15%	71,374 $368,000
Q4 2022 Feb 14, 2023	BUY	$6.09 - $8.25 $17,052 - $23,100	2,800 Added 3.78%	76,874 $468,000
Q3 2022 Nov 14, 2022	BUY	$7.04 - $9.1 $51,392 - $66,430	7,300 Added 10.93%	74,074 $554,000
Q1 2022 May 13, 2022	BUY	$8.0 - $10.06 $82,400 - $103,618	10,300 Added 18.24%	66,774 $644,000
Q4 2021 Feb 14, 2022	BUY	$8.0 - $9.74 $28,792 - $35,054	3,599 Added 6.81%	56,474 $452,000
Q3 2021 Nov 15, 2021	BUY	$8.54 - $10.24 $451,552 - $541,440	52,875 New	52,875 $495,000

Others Institutions Holding ICCC

# of Institutions

Shares Held

1.13M

Call Options Held

Put Options Held

View Full List

About IMMUCELL CORP

Ticker ICCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,746,860
Market Cap $27.7M
Description
ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive ...

More about ICCC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account